Eledon Pharmaceuticals Inc expected to post a loss of 75cents a share - Earnings Preview

Eledon Pharmaceuticals

22/03/2022 20:03

* Eledon Pharmaceuticals Inc  ELDN.OQ   ELDN.O  is expected
to show no change in quarterly revenue when it reports 
results on March 24. 
    * ​Refinitiv's mean analyst estimate for Eledon
Pharmaceuticals
Inc is for a loss of 75 cents per share. For the same quarter
last year, the company reported a loss of $2.12 per share.
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Eledon
Pharmaceuticals Inc is $25​, above​ its last closing price
of $3.46. ​​​
    * Previous quarterly performance (using preferred earnings
measure
in US dollars). ​

 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Sep. 30 2021  -0.63       -0.65      -0.66     Missed  -2.2
 Jun. 30 2021  -0.58       -0.57      -0.50     Beat    11.9
 Mar. 31 2021  -0.34       -0.32      -0.57     Missed  -78.1​
 Dec. 31 2020  -0.31       -1.39      -2.12     Missed  -52
 ​​Sep.        -1.82       -1.75      -5.51     Missed  -215.5
 30 2020                                                
 Jun. 30 2020  -2.70       -2.97      -2.16     Beat    27.3​
 Mar. 31 2020  -2.86       -2.88      -3.42     Missed  -18.7
 Dec. 31 2019  -4.66       -4.68      -3.24     Beat    30.8
 This summary was machine generated March 22 at 20:03 GMT.  All
figures in US dollars  unless otherwise stated